Release of intestinal 5-hydroxytryptamine by morphine and related agents.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D007275:Injections, Intravenous; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000187:drug effects*; D007981:Levorphanol / Q000494:pharmacology; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008691:Methadone / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology*; D009269:Nalorphine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D013618:Tachyphylaxis; D014599:Uterus / Q000187:drug effects
D007981:Levorphanol; D012701:Serotonin; D009538:Nicotine; D009020:Morphine; D012110:Reserpine; D008614:Meperidine; D003042:Cocaine; D001058:Apomorphine; D000109:Acetylcholine; D002118:Calcium; D009269:Nalorphine; D008691:Methadone